Parent-offspring regression to estimate the heritability of an HIV-1 trait in a realistic setup

Parent-offspring regression to estimate the heritability of an HIV-1 trait in a realistic setup

Background Parent-offspring (PO) regression is a central tool to determine the heritability of phenotypic traits; i.e., the relative extent to which those traits are controlled by genetic factors. The applicability of PO regression to viral traits is unclear because the direction of...

Full description

Bibliographic Details
Main Authors:	Bachmann, Nadine, Turk, Teja, Kadelka, Claus, Marzel, Alex, Shilaih, Mohaned, Böni, Jürg, Aubert, Vincent, Klimkait, Thomas, Leventhal, Gabriel E, Günthard, Huldrych F, Kouyos, Roger, Günthard, Huldrych F., Swiss HIV Cohort Study, Leventhal, Gabriel Etan
Other Authors:	Massachusetts Institute of Technology. Department of Civil and Environmental Engineering
Format:	Article
Language:	English
Published:	BioMed Central 2017
Online Access:	http://hdl.handle.net/1721.1/109413

Similar Items

Parent-offspring regression to estimate the heritability of an HIV-1 trait in a realistic setup
by: Nadine Bachmann, et al.
Published: (2017-05-01)

Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds.
by: Wan-Lin Yang, et al.
Published: (2015-03-01)

Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis
by: Teja Turk, et al.
Published: (2017-09-01)

Inferring epidemic contact structure from phylogenetic trees.
by: Gabriel E Leventhal, et al.
Published: (2012-01-01)

Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART
by: Chenjie Wan, et al.
Published: (2020-11-01)

Assessing predicted HIV-1 replicative capacity in a clinical setting.
by: Roger D Kouyos, et al.
Published: (2011-11-01)

Phylodynamics on local sexual contact networks.
by: David A Rasmussen, et al.
Published: (2017-03-01)

Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure.
by: Pedram Sendi, et al.
Published: (2007-01-01)

Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens.
by: Alexandra U Scherrer, et al.
Published: (2012-01-01)

Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study.
by: Viktor von Wyl, et al.
Published: (2013-01-01)

Detecting Selection in the HIV-1 Genome during Sexual Transmission Events
by: David Seifert, et al.
Published: (2022-02-01)

Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.
by: Alexandra U Scherrer, et al.
Published: (2012-01-01)

An Approach to Quantifying the Interaction between Behavioral and Transmission Clusters
by: Luisa Salazar-Vizcaya, et al.
Published: (2022-04-01)

Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.
by: Samuel Alizon, et al.
Published: (2010-09-01)

Emergence of Resistance to Integrase Strand Transfer Inhibitors during Dolutegravir Containing Triple-Therapy in a Treatment-Experienced Patient with Pre-Existing M184V/I Mutation
by: Dominique L. Braun, et al.
Published: (2020-11-01)

The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients.
by: Niko Beerenwinkel, et al.
Published: (2013-01-01)

HIV-1 integration sites in CD4+ T cells during primary, chronic, and late presentation of HIV-1 infection
by: Yik Lim Kok, et al.
Published: (2021-05-01)

Quantifying the turnover of transcriptional subclasses of HIV-1-infected cells.
by: Christian L Althaus, et al.
Published: (2014-10-01)

Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link
by: Huyen Nguyen, et al.
Published: (2021-06-01)

Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients
by: Katharina Kusejko, et al.
Published: (2022-07-01)

Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV.
by: Katharina Kusejko, et al.
Published: (2020-12-01)

Unsupervised machine learning predicts future sexual behaviour and sexually transmitted infections among HIV-positive men who have sex with men.
by: Sara Andresen, et al.
Published: (2022-10-01)

Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patterns.
by: Jörg Schüpbach, et al.
Published: (2013-01-01)

Disentangling human tolerance and resistance against HIV.
by: Roland R Regoes, et al.
Published: (2014-09-01)

Assessing the potential impact of transmission during prolonged viral shedding on the effect of lockdown relaxation on COVID-19.
by: Burcu Tepekule, et al.
Published: (2021-01-01)

Comparing mutational pathways to lopinavir resistance in HIV-1 subtypes B versus C.
by: Susana Posada-Céspedes, et al.
Published: (2021-09-01)

Data linkage to evaluate the long-term risk of HIV infection in individuals seeking post-exposure prophylaxis
by: Frédérique Hovaguimian, et al.
Published: (2021-02-01)

A novel Acute Retroviral Syndrome Severity Score predicts the key surrogate markers for HIV-1 disease progression.
by: Dominique L Braun, et al.
Published: (2014-01-01)

Long-term trends of alanine aminotransferase levels among persons living with human immunodeficiency virus/hepatitis B virus with and without hepatitis delta coinfection
by: Lorin Begré, et al.
Published: (2022-09-01)

Migrating a Well-Established Longitudinal Cohort Database From Oracle SQL to Research Electronic Data Entry (REDCap): Data Management Research and Design Study
by: Katharina Kusejko, et al.
Published: (2023-05-01)

Assessing the drivers of syphilis among men who have sex with men in Switzerland reveals a key impact of screening frequency: A modelling study
by: Suraj Balakrishna, et al.
Published: (2021-10-01)

Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.
by: Oliver F Brandenberg, et al.
Published: (2017-05-01)

The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study
by: Bernard Surial, et al.
Published: (2021-01-01)

Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals.
by: Margalida Rotger, et al.
Published: (2010-02-01)

HCV Genetic Diversity Can Be Used to Infer Infection Recency and Time since Infection
by: Louisa A. Carlisle, et al.
Published: (2020-10-01)

Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies.
by: Irene A Abela, et al.
Published: (2012-01-01)

Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
by: Tracy R Glass, et al.
Published: (2012-01-01)

High-throughput sequencing of human immunoglobulin variable regions with subtype identification.
by: Merle Schanz, et al.
Published: (2014-01-01)

A Novel High Throughput, Parallel Infection Assay for Determining the Replication Capacities of 346 Primary HIV-1 Isolates of the Zurich Primary HIV-1 Infection Study in Primary Cells
by: Audrey E. Rindler, et al.
Published: (2021-03-01)

Do we cause false positives? An experimental series on droplet or airborne SARS-CoV-2 contamination of sampling tubes during swab collection in a test center
by: Thomas Scheier, et al.
Published: (2021-03-01)